Vimarsana
Biggest News Aggregation in the World

Page 5 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

An App for ED? - Vimarsana News

An App for ED?

A mobile application improved erectile function during a 12-week trial, researchers report.

Smartphone App Detects Early Signs of FTD - Vimarsana News

Smartphone App Detects Early Signs of FTD

Cognitive assessments administered via a smartphone app proved accurate and reliable in detecting frontotemporal dementia in high-risk individuals.

Review Describes Semaglutide-Associated Skin Effects - Vimarsana News

Review Describes Semaglutide-Associated Skin Effects

Alopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug.

Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure - Vimarsana News

Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that the results from two proof-of-concept studies, RED DESERT and SAHARA, of the Company’s DSR therapy in patients with diuretic-resistant heart failure have been published in the prestigious pe

Source: yahoo.com
Multiple Sclerosis and Epstein-Barr Virus: What Do We Know? - Vimarsana News

Multiple Sclerosis and Epstein-Barr Virus: What Do We Know?

Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?